BioCentury | Apr 4, 2020
Management Tracks

CureVac names Stéphenne chairman; plus Desmond-Hellmann to Pfizer’s board, Reagan-Udall, Kyowa Kirin, Assembly, BioCryst and more

...member, will become CEO. Before joining the RNA-targeting gene therapy company, he was CEO of Utility Therapeutics Ltd....
BioCentury | Sep 25, 2018
Company News

Management tracks: Curis, Gemphire

...regulatory affairs. He was senior director of regulatory affairs at Allergan plc (NYSE:AGN). Antibiotic company Utility therapeutics Ltd....
Items per page:
1 - 2 of 2
BioCentury | Apr 4, 2020
Management Tracks

CureVac names Stéphenne chairman; plus Desmond-Hellmann to Pfizer’s board, Reagan-Udall, Kyowa Kirin, Assembly, BioCryst and more

...member, will become CEO. Before joining the RNA-targeting gene therapy company, he was CEO of Utility Therapeutics Ltd....
BioCentury | Sep 25, 2018
Company News

Management tracks: Curis, Gemphire

...regulatory affairs. He was senior director of regulatory affairs at Allergan plc (NYSE:AGN). Antibiotic company Utility therapeutics Ltd....
Items per page:
1 - 2 of 2